Abstract:Hemiparkinsonism duration in patients with Parkinson's disease (PD) is a key time window to study early pathology of PD. We aimed to comprehensively explore the alterations of deformation and structural network in PD patients with hemiparkinsonism, which could potentially disclose the early biomarker for PD. Thirty-one PD patients with hemiparkinsonism and 37 age- and gender- matched normal controls were included in the present study. First of all, we normalized the left hemisphere of structural images as the contralateral side to the affected limbs. Deformation-based morphometry (DBM) was conducted to evaluate the brain atrophy and/or enlargement. structural networks were constructed by thresholding gray matter volume correlation matrices of 116 regions and analyzed using graph theoretical approaches (e.g., small-worldness, global, and nodal measures). Significantly decreased deformation values were observed in the temporoparietal regions like bilateral middle temporal gyri, ipsilateral precuneus and contralateral Rolandic operculum extending to supramarginal and postcentral gyri. Lower deformation values in contralateral middle temporal gyrus were negatively correlated with higher motor impairment which was dominated by akinesia/rigidity. Moreover, nodal reorganization of structural network mainly located in frontal, temporal, subcortex and cerebellum was bilaterally explored in PD patients with hemiparkinsonism. Increased nodal properties could be commonly observed in frontal lobes. Disruption of subcortex including basal ganglia and amygdala was detected by nodal local efficiency and nodal clustering coefficient. Twelve hubs, mainly from paralimbic-limbic and heteromodal networks, were disrupted and, alternatively, 14 hubs, most of which were located in frontal lobes, were additionally detected in PD patients with hemiparkinsonism. In conclusion, during hemiparkinsonism period, mild brain atrophy in the temporoparietal regions and widespread reorganization of structural network, e.g., enhanced frontal function and disruption of basal ganglia nodes, occurred in both hemispheres. With our data, we can also argue that MTG contralateral to the affected limbs (expressing clinically verified brain atrophy) might be a potential living biomarker to monitor disease progression. Therefore, the combination of DBM and structural network analyses can provide a comprehensive and sensitive evaluation for potential pathogenesis of early PD patients with hemiparkinsonism.

Gray Matter Volume Loss in Proposed Brain-First and Body-First Parkinson's Disease Subtypes

Disrupted morphological grey matter networks in early-stage Parkinson’s disease

Clinical and imaging evidence of brain-first and body-first Parkinson's disease

Identification of Parkinson's disease subtypes with distinct brain atrophy progression and its association with clinical progression

Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s disease

Grey matter volume differences across Parkinson's disease motor subtypes in the supplementary motor cortex

Disease Progression in Proposed Brain-First and Body-First Parkinson’s Disease Subtypes

Brain-first vs. body-first Parkinson's disease: An update on recent evidence

Different Patterns of Gray Matter Density in Early- and Middle-Late-onset Parkinson’s Disease: a Voxel-Based Morphometry Study

Differences in gray matter atrophy and functional connectivity between motor subtypes of Parkinson's disease

Disease progression in proposed brain-first and body-first Parkinson's disease subtypes

Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson's Disease.

Gray and white matter alterations in different predominant side and type of motor symptom in Parkinson's disease

Morphologic changes in the mesolimbic pathway in Parkinson's disease motor subtypes

Greater loss of white matter integrity in postural instability and gait difficulty subtype of Parkinson's disease.

Grey Matter Abnormalities in Parkinson's Disease: a Voxel-Wise Meta-Analysis.

Exploring brain asymmetry in early-stage Parkinson's disease through functional and structural MRI

Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia

Brain Atrophy and Reorganization of Structural Network in Parkinson's Disease with Hemiparkinsonism

White and gray matter alterations in de novo PD patients: which matter most?

Gray matter atrophy in progressive supranuclear palsy: meta-analysis of voxel-based morphometry studies